biotech and
digital health

We are a
venture fund

Our raison d'être

We invest in the innovators behind the miracles of science who are passionate about improving human health. Sanofi Ventures serves as an entry point to the innovation ecosystem for Sanofi, strategically investing in early-stage transformational science and technology, when companies are too early to partner with or acquire.

Our Approach

We invest in top-tier biotech and digital health companies that focus on helping patients and transforming the practice of medicine. We invest across all stages of the private company lifecycle, from Seed to Series B and beyond, while leading financings, serving on boards, and taking pride in working alongside portfolio companies to drive long-term value.

Our Team

We love to meet entrepreneurs and hear about what they are doing. Feel free to reach out to us…

Our Portfolio
Strategic Wins
Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Development and Commercialization of Losmapimod in Facioscapulohumeral Muscular Dystrophy
Evidation Extends Collaboration with Sanofi to Develop and Apply Real-World Evidence
i2O Therapeutics Announces Research Collaboration with Sanofi to Enable Oral Delivery of Nanobody-Based Medicines
Kymera Therapeutics and Sanofi Enter into Strategic Partnership to Advance Novel Protein Degrader Therapies to Patients
Sanofi and Aetion launch enterprise-wide collaboration to advance regulatory submissions using real-world evidence
Science 37 and Sanofi Introduce a New Partnership
Sanofi Pasteur and Immune Design Enter Broad Collaboration for the Development of a Herpes Simplex Virus Therapy
Sanofi Licenses Immune Design's GLAAS Platform to Explore Novel Approach to Treat Food Allergy